Plaud One uses AI earbuds and a 4G-connected case to record, summarize, and act on workplace conversations without relying on ...

The US FDA has cleared the Aletta robotic system for automated blood draws in adult outpatients. Developed by Netherlands-based Vitestro, the device is designed to improve lab efficiency by allowing ...

Ask any photographer or filmmaker what quietly eats their desk space and the answer is usually the same: a tangle of chargers. Camera batteries, phone, laptop, wireless mics, an action camera, a drone ...

The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient's arm. Marketing authorization was granted to Vitestro. The device ...

Vitestro received FDA authorization for Aletta, a standalone robotic device capable of drawing blood from a patient's arm without hands-on operator involvement. The FDA granted the authorization ...

The US Food and Drug Administration (FDA) authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention. The device is ...

Aletta autonomously conducts every step of a blood draw, “from placing the tourniquet to applying the bandage.” [Photo courtesy of Vitestro] The FDA granted de novo classification to a standalone ...

THURSDAY, Aug. 20, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has authorized the Aletta as the first standalone robotic device that can draw blood from a patient's arm. The device ...

WASHINGTON (WDNews) — The U.S. Food and Drug Administration has authorized the first standalone robotic device capable of drawing blood from a patient’s arm without hands-on help from an operator.

The FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help. The approval, the FDA said in a release, will ...